Akut mieloid leukémia (AML): vizsgálatok itt: Franciaország
88 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleSafety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML
- Where
- Grenoble, Le Mans, Lille, Marseille, Nice, Nîmes, Paris, Rouen
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06191263 - 2. fázisTaking peopleRVU120 Rollover Study
- Where
- Nice, Pessac
- Életkor
- 18 év and over
- People
- 14 worldwide
- Run by
- Ryvu Therapeutics SA
See details and how to joinNCT06987058 · EU 2025-521673-14-00 - 2. fázisNot yet taking people in FranciaországFILO-AML-01-MIVONU A single arm phase II study investigating the efficacy and safety of the addition of ivosidenib to oral azacitidine (Onureg®) in patients over 55 with Acute Myeloid Leukemia (AML) and IDH1 mutation, in complete remission after intensive chemotherapy. A study of the French AML Intergroup.
- Where
- ANGERS Cedex 09, Bayonne, Besançon Cedex, Clamart, Créteil Cedex, Grenoble Cedex 9, Lille, Limoges Cedex, Nantes, Nimes Cedex 9, Paris, Perpignan Cedex, Pessac, Pierre-Bénite, Rennes, Rouen, Toulouse Cedex 9, Tours Cedex 9, Vandoeuvre Les Nancy, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 60
- Run by
- French Innovative Leukemia Organization
See details and how to join2025-521322-14-00 - 2. fázisFut, nem toboroz(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Paris, Poitiers, Toulouse
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 1/2. fázisTaking peopleA Study of BGB-11417 in Participants With Myeloid Malignancies
- Where
- Lille Cedex, Nice, Paris
- Életkor
- 18 év and over
- People
- 260 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT04771130 · EU 2023-508881-14-00 - No phaseTaking peopleRegistry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
- Where
- Rouen
- Életkor
- 18 év and over
- People
- 6990
- Run by
- Groupe Francophone des Myelodysplasies
See details and how to joinNCT06956755 - 2/3. fázisNot yet taking people in FranciaországA Study to Assess How Well the Study Medicine IPN60340 Works in Combination With Azacitidine and Venetoclax, Compared to Placebo in Combination With Azacitidine and Venetoclax, in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Cannot Receive Intensive Chemotherapy
- Where
- Limoges, Marseille, Nantes, Nice, Pessac, Pierre-Bénite
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Ipsen
See details and how to joinNCT07623187 · EU 2026-526320-44-00 - No phaseTaking peopleBiological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
- Where
- Nantes
- Életkor
- 18 év to 99 év
- People
- 60
- Run by
- Nantes University Hospital
See details and how to joinNCT06439199 - 3. fázisTaking peopleRevumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
- Where
- Amiens Cedex 1, Angers, Besancon Cedex, Caen Cedex 9, Clamart, Clermont-Ferrand, Creteil Cedex, Grenoble Cedex 9, Le Chesnay Rocquencourt, Lille Cedex, Limoges Cedex 1, Metz Cedex 03, Montpellier Cedex 5, Nantes, Nice, Pessac, Pierre-Bénite, Rouen Cedex, Saint-Priest-en-Jarez, Strasbourg Cedex 2
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06652438 · EU 2024-512733-32-00 - 1/2. fázisTaking peopleStudy Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)
- Where
- Paris, Pessac, Toulouse, Villejuif
- Életkor
- 18 év to 66 év
- People
- 10
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04707300 - 2/3. fázisNot yet taking people in FranciaországL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- ANGERS Cedex 09, Grenoble, Paris, Strasbourg
- Életkor
- 18 év to 80 év
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - 2. fázisCsak meghívásosA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Mulhouse
- Életkor
- 18 év and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - 1/2. fázisNot yet taking people in FranciaországVenetoclax in Association With 3+7 and Midostaurin in FLT3-mutated Acute Myeloid Leukemia
- Where
- Bayonne, Pessac, Toulouse
- Életkor
- 18 év to 70 év
- People
- 41
- Run by
- University Hospital, Bordeaux
See details and how to joinNCT07726576 - 1. fázisTaking peopleA Study to Assess Adverse Events and How Pivekimab Sunirine Moves Through the Body of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Bordeaux, Paris
- Életkor
- Up to 17 év
- People
- 18 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-520125-36-00 - 1/2. fázisNot yet taking people in FranciaországA Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- Where
- Marseille, Nice, Paris, Pessac Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00 - 2/3. fázisBefejeződöttStudy to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
- Where
- Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon Cedex 9, Bayonne, Besançon, Béziers, Bobigny, Boulogne-sur-Mer, Brest Cedex 2, Caen Cedex 9, Clamart, Clermont-Ferrand, Colmar Cedex, Corbeil Essonnes Cedex, Creteil Cedex, Dijon, Dunkirk Cedex 1, Grenoble Cedex 9, Le Chesnay Rocquencourt, Lens, Lille Cedex, Limoges Cedex 1, Lyon, Marseille, Meaux, Metz Cedex 03, Montpellier Cedex 5, Mulhouse, Nantes, Nice, Nice Cedex 2, Nimes Cedex 9, Orleans Cedex 2, Paris, Perpignan Cedex, Pessac, Pierre-Bénite, Poitiers, Pontoise, Reims Cedex, Rennes, Roubaix, Rouen Cedex, Saint-Cloud, Saint-Denis, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse Cedex 9, Tours Cedex 9, Valenciennes, Vandoeuvre Les Nancy, Villejuif
- Életkor
- 18 év to 61 év
- People
- 3100
- Run by
- University Hospital, Angers
See details and how to joinNCT02416388 · EU 2024-516873-57-00 - 3. fázisTaking peopleFLUCLORIC - Randomized multicentric Phase III study comparing the efficacy of two reduced intensity conditioning regimens (clofarabine/busulfan versus fludarabine/busulfan) in adults with acute myeloid leukemia and eligible to allogeneic stem cell transplantation: a SFGM-TC study
- Where
- Amiens, Angers Cedex 9, Besancon Cedex, Brest, Caen Cedex 9, Clermont-Ferrand, Creteil Cedex, Grenoble Cedex 9, Lille Cedex, Limoges Cedex 1, Marseille, Montpellier Cedex 5, Nantes Cedex 1, Paris, Paris Cedex 12, Paris Cedex 13, Pessac, Pierre-Bénite, Poitiers, Rennes Cedex 9, Saint-Priest-en-Jarez, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 18 év and over
- People
- 302
- Run by
- Centre Hospitalier Universitaire De Nantes
See details and how to join2022-502019-12-00 - No phaseTaking peopleBiocollection in MyeloDysplastic Syndrome (P-MDS)
- Where
- Brest
- Életkor
- 18 év and over
- People
- 150
- Run by
- University Hospital, Brest
See details and how to joinNCT04869683 - 1. fázisTaking peopleEscalation of Doses of Daratumumab in Combination With Chemotherapy (Idarubicin and Cytarabine or CPX-351) in Patients of 60 Years Old or More With Adverse Risk Acute Myeloblastic Leukemia (AML) (DARALAM)
- Where
- Nantes
- Életkor
- 60 év and over
- People
- 12
- Run by
- Nantes University Hospital
See details and how to joinNCT05749276 - 1/2. fázisBefejeződöttStudy to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Where
- Bordeaux, Villejuif
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- CellCentric Ltd.
See details and how to joinNCT04068597 - No phaseNot yet taking people in FranciaországStudy of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 55
- Run by
- Nantes University Hospital
See details and how to joinNCT07249476 - 1. fázisTaking peopleStudy of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
- Where
- Marseille, Pessac, Pierre-Bénite, Villejuif
- Életkor
- 18 év and over
- People
- 291 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT02074839 - 1/2. fázisTaking peopleACTIVATE - Phase 1 Clinical Trial evaluating the combination of Actinomycin D and venetoclax in patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
- Where
- Bobigny, Marseille, Nice, Paris, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 36
- Run by
- Assistance Publique Hopitaux De Paris
See details and how to join2025-524728-22-01 - No phaseTaking peopleCreation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Nantes University Hospital
See details and how to joinNCT06681363 - 1/2. fázisNot yet taking people in FranciaországPhase 1/2 evaluating the addition of venetoclax to standard 3+7 and midostaurin induction treatment in patients with FLT3-mutated Acute Myeloid Leukemia eligible to intensive chemotherapy - MIDOVEN
- Where
- Bayonne, Pessac, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 41
- Run by
- Centre Hospitalier Universitaire De Bordeaux
See details and how to join2024-517130-17-00